{"schema_version":"1","generated_at":"2026-11-05T07:44:00.258Z","data_as_of":null,"url":"https://www.findmykol.com/kol/samuel-shelburne","json_url":"https://www.findmykol.com/kol/samuel-shelburne/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"samuel-shelburne","name":"Samuel Shelburne","credential":"MD","specialty":"Infectious Disease","specialty_raw":"Infectious Disease","therapeutic_area":"Infectious Disease","therapeutic_areas":["Infectious Disease"],"institution":"The University of Texas MD Anderson Cancer Center","institution_url":"https://www.findmykol.com/institution/the-university-of-texas-md-anderson-cancer-center","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1841389319","orcid":"0000-0001-9721-263X","openalex":"A5080337533"},"summary":"Samuel Shelburne is an Infectious Disease physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 286 publications with 13,789 citations (h-index 50). By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the FindMyKOL directory.","overview":null,"focus":{"indications":[],"research_topics":["Infectious Disease"]},"scholarship":{"works_count":286,"cited_by_count":13789,"h_index":50,"latest_activity_year":2026,"citation_standing":{"top_percent":10,"cohort":"Infectious Disease","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Anti-infectives","share_pct":100,"classes_total":4,"classes":[{"class":"Short-acting sulfonamides","setting":"prescribed","share_pct":32,"drugs":[{"name":"Sulfamethoxazole-Trimethoprim","share_pct":100}],"max_beneficiaries":null},{"class":"Penicillins with extended spectrum","setting":"prescribed","share_pct":24,"drugs":[{"name":"Amoxicillin-Clavulanate Potass","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":33.8,"facility_pct":66.2},"source":"medicare"},"funding":{"award_count":11,"fiscal_years":{"first":2006,"last":2026},"rows_total":38,"shown":3,"withheld":35,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"P30CA016672","title":"Microbiome Shared Resource (MSR)","fiscal_year":2026,"amount_usd":"141423","organization":"UNIVERSITY OF TX MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/P30CA016672"},{"project":"P01AI152999","title":"Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)","fiscal_year":2025,"amount_usd":"2377848","organization":"METHODIST HOSPITAL RESEARCH INSTITUTE","source_url":"https://reporter.nih.gov/quickSearch/P01AI152999"},{"project":"P01AI152999","title":"Project 2: Leveraging Metagenomics of the Microbiome to predict colonization/infection by antimicrobial-resistant pathogens","fiscal_year":2025,"amount_usd":"474264","organization":"METHODIST HOSPITAL RESEARCH INSTITUTE","source_url":"https://reporter.nih.gov/quickSearch/P01AI152999"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Dalbavancin for Treatment of Staphylococcus aureus Bacteremia","year":2025,"journal":"JAMA","source_url":"https://doi.org/10.1001/jama.2025.12543","status":"verified"},{"title":"AI is a viable alternative to high throughput screening: a 318-target study","year":2024,"journal":"Scientific Reports","source_url":"https://doi.org/10.1038/s41598-024-54655-z","status":"verified"},{"title":"Clinical challenges treatingStenotrophomonas maltophiliainfections: an update","year":2022,"journal":"JAC-Antimicrobial Resistance","source_url":"https://doi.org/10.1093/jacamr/dlac040","status":"verified"},{"title":"Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease","year":2022,"journal":"Cell","source_url":"https://doi.org/10.1016/j.cell.2022.09.007","status":"verified"},{"title":"Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment","year":2022,"journal":"Science Translational Medicine","source_url":"https://doi.org/10.1126/scitranslmed.abo3445","status":"verified"}],"source":"works"},"contact":{"address_1":"1515 HOLCOMBE BLVD","city":"Houston","state":"TX","zip":"770304009","phone":"713-792-6161","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1841389319","source":"identity"},"similar":[{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Jaffer Ajani","slug":"jaffer-ajani","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jaffer-ajani","json_url":"https://www.findmykol.com/kol/jaffer-ajani/profile.json"},{"name":"Funda Meric-Bernstam","slug":"funda-meric-bernstam","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Surgery","url":"https://www.findmykol.com/kol/funda-meric-bernstam","json_url":"https://www.findmykol.com/kol/funda-meric-bernstam/profile.json"},{"name":"Thomas Walsh","slug":"thomas-walsh","institution":"Cornell University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/thomas-walsh","json_url":"https://www.findmykol.com/kol/thomas-walsh/profile.json"},{"name":"Douglas Richman","slug":"douglas-richman","institution":"University of California San Diego","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/douglas-richman","json_url":"https://www.findmykol.com/kol/douglas-richman/profile.json"},{"name":"Henry Masur","slug":"henry-masur","institution":"National Institutes of Health","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/henry-masur","json_url":"https://www.findmykol.com/kol/henry-masur/profile.json"},{"name":"Vance Fowler","slug":"vance-fowler","institution":"Duke University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/vance-fowler","json_url":"https://www.findmykol.com/kol/vance-fowler/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":35,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-01-22","provider_certified":"2021-01-22","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}